Objective: Nicorandil is used clinically to treat angina and acts in part by opening ATP-sensitive K q channels whose opening is also enhanced by metabolic compromise. We have therefore investigated whether treatments that mimic conditions in ischaemia can increase the potency of nicorandil to dilate coronary arteries. Methods: Ring segments from pig small coronary arteries were mounted on a myograph, contracted with 20 mM K . " 0.01, n s 7 , and abolished its enhancement by CCCP, zero glucose, 2-CA or pH 6.8 solution. 2-CA did not affect the potency of nicorandil in relaxing contractions to 80 mM K q or the potency of glyceryl trinitrate. We conclude that the potency of nicorandil to cause coronary vasorelaxation is increased under conditions of metabolic inhibition. This effect appears to result from the K q channel opening action of the drug, and may have significant consequences for its therapeutic effectiveness. q 1998 Elsevier Science B.V.
Introduction
The vasodilator nicorandil is a nicotinamide derivative w x used clinically for the treatment of angina 1,2 . Nicorandil has at least two mechanisms of action; it acts as a K q channel opener and also has a nitrovasodilator action, activating guanylyl cyclase and so increasing guanosine X X Ž .w x 3 :5 -cyclic monophosphate cGMP 3,4 . The contribution of these two pathways to vasorelaxation appears to vary according to the tissue under study and the concentration of nicorandil used, the relative importance of the K q channel opening mechanism being greater in small vessels w x and at lower concentrations of nicorandil 4-6 . Clinically, in contrast to other nitrovasodilators, tolerance does not develop on continued application of nicorandil, and this ) Ž . Ž . Corresponding author. Tel. q44-116 252 3302; Fax q44-116 252 5045; E-mail: nbs@le.ac.uk lack of tolerance seems to be due its K q channel opening w x action 1 .
In common with the 'pure' K q channel openers such as levcromakalim and pinacidil, nicorandil activates glibenclamide-sensitive channels of the ATP-sensitive K q chan-Ž . Ž w x . nel K family see 7 for review . Such channels in ATP vascular smooth muscle respond to the metabolic state of the cell, and may be activated by metabolic inhibitors or w x by hypoxia 8-11 . Further, adenosine, which may play a role in matching blood flow to tissue demand in the coronary circulation can also activate these channels w x 12,13 . The metabolic sensitivity of K channels sug-ATP gests that K q channel openers might be more potent in ischaemic tissue, where metabolism is compromised. Evidence for this has been obtained by Randall and Griffith w x 14 who showed that the vasorelaxant action of levcro-
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Downloaded from https://academic.oup.com/cardiovascres/article-abstract/37/3/791/321151 by guest on 09 January 2018 ( )makalim in the rabbit ear artery was enhanced by inhibition of oxidative metabolism or by hypoxia, an effect that may be mediated by activation of receptors by adenosine w x released as a consequence of hypoxia 15 . Interestingly, however, the potency of another opener of K channels, ATP pinacidil, was unaffected by either hypoxia or adenosine receptor activation, suggesting that the effect depends on the exact mechanism of interaction of the opener with the w x K channel 14,15 . In contrast to these findings in the ATP rabbit ear, hypoxia and low extracellular glucose have been reported to reduce the effectiveness of levcromakalim w x in relaxing strips of rat aorta 16 .
Since nicorandil has the dual action described above, it is possible that its potency might also be enhanced by metabolic compromise, provided that K q channel opening contributes significantly to its relaxant action in the tissue concerned, and that its K q channel opening action resembles that of levcromakalim rather than pinacidil. In view of the current clinical use of nicorandil as an anti-anginal agent, we have therefore investigated whether its potency in relaxing coronary arteries is increased by treatments designed to mimic those that might occur in ischaemia. Using rings from small branches of pig coronary artery we find that the relaxant action of nicorandil is enhanced in the presence of the inhibitor of oxidative phosphorylation carbonyl cyanide m-chlorophenyl hydrazone, by removal of extracellular glucose, by the adenosine analogue 2-chloroadenosine, or by lowering the extracellular pH to 6.8. Our results are consistent with nicorandil acting as a more effective vasodilator in ischaemic tissue.
Materials and methods

Myography
Pig hearts were obtained from a local abattoir, after animals had been slaughtered in accordance with EEC Ž regulations, and second or third order branches mean . outer diameter 358 " 21 mm, n s 36 were dissected from the left anterior descending coronary artery and cut into 2 mm ring segments. Dissection was done in ice cold saline Ž . solution containing mM : 125 NaCl, 5 KCl, 1.8 CaCl , 1 2 MgCl , 10 HEPES, 10 glucose. Two rings were mounted 2 w xŽ . in a small vessel wire myograph 17,18 JP Trading . The rings were placed in a 10 ml bath maintained at 378C. All chemicals were added directly to the bath. All the solutions Ž . contained 20 mM L-nitro arginine methyl ester L-NAME to eliminate endogenous nitric oxide activity. The vessels q Ž were contracted using 20 mM K Krebs solution in mM: 20 KCl, 125 NaCl, 1. 
Data analysis
Ž . The decrease in tone relaxation was measured from the maximal contraction generated with 20KrBAYK. The difference between the maximum tone and the baseline just prior to the contraction was calculated and used to convert the values to a percentage relaxation. All values are given as means " S.E.M. Individual concentration response curves were fitted with the expression ( )chloroadenosine and BAYK 8644, RBI; glyceryl trinitrate, Lipha. Table 2 .
Results
Effects of metabolic inhibition on the potency of nicorandil
To inhibit oxidative metabolism, we used carbonyl Ž . cyanide m-chlorophenylhydrazone CCCP, 100 nM which uncouples electron transfer in the respiratory chain. CCCP caused a small reduction in the maximum contractile force elicited by 20KrBAYK, from a control value of 14.1 " 2.7 Ž . mN to 12.6 " 2.5 mN n s 8, P s 0.06, paired t-test . In the presence of CCCP, nicorandil was more potent at causing vasorelaxation, its concentration-response curve being shifted to the left, with a pEC of 5.11 " 0.08 and a Table 1 , Ž while the maximal relaxation was unaffected 96.2 " . 1.1% . pEC and Hill coefficient values for nicorandil 50 under control conditions and in the presence of CCCP and other agents and are given in Table 1 . In common with the other experimental conditions we used that increased the Ž potency of nicorandil zero glucose, reduced pH and 2-. chloroadenosine, see below , the effect of CCCP was Ž . abolished by glibenclamide 10 mM . Glibenclamide shifted the concentration-effect curve for nicorandil to the right, reducing the pEC to 3.95 " 0.07, a value not 50 significantly different from that in the absence of CCCP Ž . Fig. 1B , Table 2 , consistent with the extra potency of nicorandil in the presence of CCCP resulting from its action on K channels.
ATP
We also investigated the effect of reducing glycolysis by removing glucose from the extracellular solution. In rat coronary arteries inhibition of glycolysis has been reported to cause vasodilation which can be reversed with gliben- 
Decreased extracellular pH
A fall in extracellular pH is a feature of hypoxia or ischaemia. Decreased internal pH is a powerful activator of w x K channels in skeletal muscle 21 , and extracellular ATP acidosis has been shown to produce dilations of pig coronary resistance arteries that are inhibited by glibenclamide, implying that K channel activation is also involved in ATP w x this vasodilation 22 . We therefore examined the effects of nicorandil under conditions where extracellular pH was reduced from its normal value of pH 7.4 to pH 6.8. This reduction in pH led to a reduction in maximal contractile Ž force, from 14.2 " 2.2 mN to 11.2 " 1.8 mN n s 9, P -. 0.05, paired t-test . Fig. 2A and Table 1 show that, though not as effective as metabolic inhibition, a reduction in Values are mean"S.E.M. There were no significant differences between groups at the P -0.05 level, ANOVA followed by Duncan's multiple range test. Ž . conditions. The curves are drawn using Eq. 1 . The broken line shows the control concentration-response curve. B. Concentration-response curves for the relaxation of pig coronary arterial rings by nicorandil in the Ž presence of 300 nM of the adenosine agonist 2-chloroadenosine`, . Ž . ns 7 , and in 2-chloroadenosine q10 mM glibenclamide B, ns 7 . The broken line shows the control concentration-response curve. external pH to 6.8 caused a small but significant increase in the potency of nicorandil, raising its pEC to 4.95 " 50 Ž . 0.06 n s 9 .
Adenosine receptor actiÕation
Adenosine released from cardiac myocytes may serve to match blood delivery to the metabolic needs of the cardiac tissue, and extracellular adenosine would be expected to w x increase under conditions of ischaemia 23,24 . Adenosine receptor activation can activate K channels of coronary ATP w x smooth muscle 12,25 , and activation of such channels by adenosine can play a role in hypoxic vasodilation in the Downloaded from https://academic.oup.com/cardiovascres/article-abstract/37/3/791/321151 by guest on 09 January 2018 ( )w x coronary circulation 26 . We used the stable analogue of adenosine, 2-chloroadenosine, which acts at both A and 1 A adenosine receptors to investigate the effect of adeno-2 sine receptor activation on the vasorelaxant potency of nicorandil. 2-Chloroadenosine caused a small reduction in the maximum contractile force elicited by 20KrBAYK Ž from 15.1 " 2.1 mN to 12.9 " 1.8 mN n s 7, P -0.05, . Ž paired t-test . Fig. 2B shows that 2-chloroadenosine 300 . nM was an effective enhancer of the potency of nicorandil to relax coronary arterial rings, raising the pEC for 50 Ž . nicorandil to 5.17 " 0.06 n s 7, Table 1 .
Relaxations in the absence of K q channel opening effects
The increases in the potency of nicorandil under conditions of metabolic inhibition, reduced pH, and adenosine receptor activation described above are consistent with such conditions increasing the activity of K channels so ATP that the K q channel opening activity of nicorandil is enhanced. Evidence that the enhancement of the potency of nicorandil is associated with its K opening action ATP comes from the observation that this effect was abolished Ž when K channels were blocked by glibenclamide 10 ATP . mM . Figs. 1 and 2 include concentration-effect curves for nicorandil measured in the presence of glibenclamide. Nicorandil was considerably less potent in the presence of glibenclamide, and its potency was unaffected by CCCP, zero glucose, 2-chloroadenosine or by reduced pH under Ž . these conditions Table 2 . To further investigate whether the increased potency of nicorandil described above could be attributed to its K q channel opening action, we investigated the effect of 2-chloroadenosine on the nicorandil relaxations of contractions to 80 mM K q external solution, rather than the 20KrBAYK used in the previous experiments. In 80 mM K q , the K q equilibrium potential should be about y16 mV, so that opening K q channels will no longer cause hyperpolarization and relaxation. Thus in 80 mM K q , K q channel opening should not contribute to the relaxant action of nicorandil, which is likely to result from the nitrovasodilator action of the drug under these conditions. Fig. 3A shows that, as expected, nicorandil was less potent in 80 mM K q than in 20 mM K q , with a pEC of 50 Ž . w q x with 2-chloroadenosine at lower external K resulting from an action on K q channels.
Relaxations to glyceryl trinitrate
We also studied the effect of adenosine receptor activation on relaxations elicited by the nitrovasodilator glyceryl trinitrate. If the enhancement of the potency of nicorandil in the presence of 2-chloroadenosine described above were related to its nitrovasodilator action, then it might be expected that the potency of drug that acts solely as a nitrovasodilator would be increased in the same way. Fig.  3B shows that this was not the case: 300nM 2-chloroadenosine did not affect the potency of glyceryl trinitrate.
Ž . The pEC for glyceryl trinitrate was 5.79 " 0.14 n s 4 50 Ž in the absence of 2-chloroadenosine, and 5.56 " 0.33 n s . Ž . 5 in its presence P s 0.57 .
Discussion
Our results show that in relatively small porcine coronary arteries the potency of nicorandil to cause vasodilation was enhanced by a number of manoeuvres designed to mimic changes that might occur under conditions where ( )tissue perfusion is compromised. Thus inhibition of oxidative metabolism with CCCP or of glycolysis with zero glucose, a reduction in pH, or activation of adenosine receptors with 2-chloroadenosine all caused significant shifts of the dose-response curve for nicorandil to lower concentrations. The mechanism by which these effects occur seems independent of effects on endogenous NO, since all of our experiments were done in the presence of L-NAME to inhibit NO synthesis. Some of the manoeuvres described led to small decreases in the tonic contractile force elicited by 20KrBAYK, but these do not account for the enhanced vasodilator potency. Thus glucose free solution did not decrease contractile force, but significantly enhanced the potency of nicorandil. Further, 2-chloroadenosine, which caused a 15% decrease in tonic force and increased the potency of nicorandil, had no effect on the vasodilator potency of glyceryl trinitrate.
Nicorandil is known to cause vasodilation by two mechanisms, acting both as a K q channel opener and as a w x nitrovasodilator 3,4 . Our evidence suggests that the changes in the potency of nicorandil that we measure under conditions of metabolic compromise result from its K q channel opening action. First, the increases in potency were abolished by the K channel blocker gliben- effective and relatively selective blocker of these channels w x at 10 mM 7,27 . Glibenclamide shifted the dose-response curve for nicorandil to the right, and rendered it insensitive to the metabolic manoeuvres described above. Secondly, Ž . 2-chloroadenosine 300 nM , which caused a marked shift in the potency of nicorandil, was ineffective when extracelw q x lular K was raised to 80 mM, which should abolish the ability of K q channel opening to cause hyperpolarization and so relaxation. Finally, the potency of a compound that acts only as a nitrovasodilator, glyceryl trinitrate, was unaffected by 2-chloroadenosine. It can also be seen from Figs. 1 and 2 and Table 1 that manoeuvres that increased the potency of nicorandil also reduced the Hill coefficient for its action, an effect that was significant with CCCP and 2-chloroadenosine. Such an effect would be expected if K q channel opening contributes a relatively greater proportion of the vasorelaxant action of nicorandil at low w x concentrations, as has been described previously 4,5 . Conditions that increase the degree of K q channel opening at a given concentration of nicorandil would then have a greater effect on relaxation at low concentrations, leading to the observed slight flattening of the concentration-effect curve. The Hill coefficient for nicorandil was also reduced q Ž in the presence of glibenclamide, or in 80 mM K Table  . 2 . Under these conditions the coefficient presumably reflects only that for the nitrovasodilator action of nicorandil. by their sensitivity to cellular metabolism. Metabolic inhibition similar to that used in our experiments has been shown to reduce ATP levels by about a third in rabbit mesenteric artery and by 59% in uterine smooth muscle w x 32,33 , and changes in other metabolites, such as an increase in ADP concentration, may also contribute to channel activation under these conditions. Adenosine receptor activation and hypoxia can both activate K ATP channels in smooth muscle cells isolated from pig corow x nary artery 10,12 . A fall in intracellular pH increases K channel activity in skeletal and cardiac muscle, ATP acting by reducing the affinity for ATP to cause channel w x inhibition 21 . It seems likely that the glibenclamide-sensitive dilation of coronary arterioles reported in response to w x acidosis 22 may result from a similar mechanism; a fall in intracellular pH occurring as a result of the acidosis and leading to channel activation. We therefore think it likely that the various procedures we have used in the present study lead to an increase in the activity of K channels.
ATP
Under these conditions a given concentration of nicorandil causes more substantial channel opening and so hyperpolarization and vasorelaxation than it does under normoxic conditions. It is clear, though, that the sensitivity of the action of K q channel openers in vascular smooth muscle to enhancement by metabolic compromise may depend both on the tissue and on the precise mechanism of interaction between the drug and the channel. Our results with nicorandil on coronary arteries are consistent with the findings using levcromakalim in the rabbit ear described by Randall and Griffith, who found that metabolic inhibition, hypoxia, and adenosine A agonists all increased the vasorelaxant 1 w x potency of levcromakalim 14,15 . However pinacidil, which also acts by opening K q channels of the K ATP family, differed from levcromakalim in that its potency was unaffected by metabolic inhibition or adenosine, suggesting different mechanisms of interaction between these w x two agents and their target channel 14,15 . Further, the potency of levcromakalim is not enhanced by metabolic inhibition in all vascular tissues, since in rat aorta neither w x hypoxia nor low glucose caused such an increase 16 , a finding that may correspond to a relatively greater role for K channels in smaller arteries, or to differences in the ATP cellular signalling pathways that contribute to their regulaDownloaded from https://academic.oup.com/cardiovascres/article-abstract/37/3/791/321151 by guest on 09 January 2018 ( )w x tion 7 . The results we report here suggest that in terms of its ability to interact with mechanisms that are activated during ischaemia, the K q channel opening action of nicorandil on coronary arteries resembles that of levcromakalim rather than pinacidil.
Our results suggest both that nicorandil activates K q channels by a mechanism that can be enhanced when their activity is increased under conditions of metabolic compromise, and that K q channel opening makes a large enough contribution to the effects of nicorandil in the coronary arteries we studied for this effect to be reflected in an increased relaxant potency for the drug. Although we have not been able to study resistance-sized vessels in these experiments, others have reported that the contribution of K q channel opening to relaxation by nicorandil in the coronary circulation becomes greater with decreasing artew x rial size 4-6 . We would therefore expect the increase in the potency of nicorandil under ischaemic conditions to be at least as great in coronary resistance vessels as those we report here.
Our findings of enhanced potency under conditions designed to simulate those in ischaemia may have significant consequences for the therapeutic actions of nicorandil in angina. Such sensitivity to the metabolic state of tissue may result in nicorandil being effectively targeted to metabolically compromised tissues, so that it exerts its maximum vasodilator effects on regions within the heart where ischaemia is most pronounced.
